ATM haplotypes and associated mutations in Iranian patients with ataxia-telangiectasia:: recurring homozygosity without a founder haplotype

被引:13
作者
Babaei, M
Mitui, M
Olson, ER
Gatti, RA
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA
[2] Benaroya Res Inst, Seattle, WA 98101 USA
关键词
D O I
10.1007/s00439-005-1254-7
中图分类号
Q3 [遗传学];
学科分类号
071007 [遗传学]; 090102 [作物遗传育种];
摘要
Ataxia - telangiectasia ( A - T) is an autosomal recessive disorder caused by mutations in the ATM gene. The ATM gene spans more than 150 kb at chromosomal region 11q23.1 and encodes a product of 3,056 amino acids. The ATM protein is a serine/ threonine protein kinase and is involved in oxidative stress, cell cycle control, and DNA repair. We analyzed the 11q22- 23 haplotypes and associated mutations of 16 Iranian families. We utilized standardized short tandem repeat ( STR) haplotypes to enhance mutation identification. In addition to the STR markers, single- nucleotide polymorphism haplotypes were determined, using three critical polymorphisms. The entire gene was screened sequentially by protein truncation testing, single- strand conformation polymorphism, and denaturing high- performance liquid chromatography to identify the disease-causing mutations. Of the expected 32 mutations, 25 ( 78%) were identified. All but two mutations led to a truncated or null form of the ATM protein ( nonsense, splice site, or frameshift). Twelve mutations were identified for 15 haplotypes. Five mutations were novel. Mutations were located throughout the entire gene, with no clustering. Despite the absence of an Iranian founder mutation, three- fourths of the families were homozygous, suggesting that many undetected ATM mutations still exist in Iran. This study establishes a database for Iranian A - T families, and extends the global spectrum of ATM mutations.
引用
收藏
页码:101 / 106
页数:6
相关论文
共 59 条
[1]
Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer [J].
Athma, P ;
Rappaport, R ;
Swift, M .
CANCER GENETICS AND CYTOGENETICS, 1996, 92 (02) :130-134
[2]
Initiating cellular stress responses [J].
Bakkenist, CJ ;
Kastan, MB .
CELL, 2004, 118 (01) :9-17
[3]
Atm-deficient mice: A paradigm of ataxia telangiectasia [J].
Barlow, C ;
Hirotsune, S ;
Paylor, R ;
Liyanage, M ;
Eckhaus, M ;
Collins, F ;
Shiloh, Y ;
Crawley, JN ;
Ried, T ;
Tagle, D ;
WynshawBoris, A .
CELL, 1996, 86 (01) :159-171
[4]
Ataxia-telangiectasia: Phenotype/genotype studies of ATM protein expression, mutations, and radiosensitivity [J].
Becker-Catania, SG ;
Chen, G ;
Hwang, MJ ;
Wang, ZJ ;
Sun, X ;
Sanal, O ;
Bernatowska-Matuszkiewicz, E ;
Chessa, L ;
Lee, EYHP ;
Gatti, RA .
MOLECULAR GENETICS AND METABOLISM, 2000, 70 (02) :122-133
[5]
Designing and implementing quality control for multi-center screening of mutations in the ATM gene among women with breast cancer [J].
Bernstein, JL ;
Teraoka, S ;
Haile, RW ;
Borresen-Dale, AL ;
Rosenstein, BS ;
Gatti, RA ;
Diep, AT ;
Jansen, L ;
Atencio, DR ;
Olsen, JH ;
Bernstein, L ;
Teitelbaum, SL ;
Thompson, WD ;
Concannon, P .
HUMAN MUTATION, 2003, 21 (05) :542-550
[6]
BIRRELL GW, 2005, IN PRESS ATM MUTATIO
[7]
CAMPBELL C, 2003, HUM MUTAT, V2, P123
[8]
Castellví-Bel S, 1999, HUM MUTAT, V14, P156, DOI 10.1002/(SICI)1098-1004(1999)14:2<156::AID-HUMU7>3.0.CO
[9]
2-E
[10]
Chenevix-Trench G, 2002, JNCI-J NATL CANCER I, V94, P205, DOI 10.1093/jnci/94.3.205